Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Hexa-Acylated LPS and Cancer Immunotherapy Response
2026-09-02
The reference study identifies the structural form of gut microbiota-derived lipopolysaccharide, rather than bacterial taxonomy alone, as a determinant of anti-PD-1 immunotherapy response. Its metagenomic, in vitro, and mouse-model experiments support hexa-acylated LPS as both a functional biomarker and a possible enhancer of antitumor immunity, while highlighting the risks of nonspecific microbiome perturbation.
-
Mitochondrial Permeability Transition Pore Assay Kit
2026-09-01
Discover how the Mitochondrial Permeability Transition Pore Assay Kit converts pore opening into a functional Calcein AM fluorescent probe readout. This guide connects assay design with recent evidence on mitochondrial ROS, cardiolipin peroxidation, and intrinsic apoptosis.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-09-01
TBST is a ready-to-use Tris-buffered saline solution containing Tween 20 for blocking, antibody dilution, and washing in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. It is intended to reduce nonspecific binding and background, but should be avoided or validated carefully when non-ionic detergents interfere with assay chemistry, antigen integrity, or detection.
-
Carbapenemase Gene Spread in Enterobacter cloacae
2026-08-31
A 2025 BMC Microbiology study maps carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong, combining gene localization, conjugation, mobile-element analysis, and strain typing. Its findings show that blaNDM-1 was frequently plasmid-associated and readily transferable, highlighting the importance of surveillance that measures both resistance mechanisms and transmission potential.
-
TPCA-1: IKK-2 Inhibitor Workflow
2026-08-31
TPCA-1 is a selective IKK-2 inhibitor for separating NF-κB-driven cytokine responses from RIPK1-dependent apoptosis and necroptosis. This workflow combines pathway, cytokine, viability, and phospho-protein readouts to improve mechanistic interpretation in inflammation research and rheumatoid arthritis research.
-
NU7441: From DNA-PK Mechanism to Translation
2026-08-30
NU7441 (KU-57788) is more than a potent DNA-PK inhibitor: it is a translational research tool for testing how DNA damage response defects, cell-cycle control, and treatment sensitivity intersect. This article connects mechanistic biology with experimental design, selectivity analysis, and oncology-focused decision-making.
-
Temafloxacin: PK-Informed Antibacterial Assays
2026-08-29
Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent with distinctive pharmacokinetic features that can improve assay design. This guide connects exposure, tissue distribution, intracellular testing, and practical compound handling without repeating a conventional pathogen-by-pathogen review.
-
From ROS Signal to Translational Strategy
2026-08-28
A mechanistic and strategic guide to using live-cell ROS measurements to connect oxidative stress, Nrf2 and EGFR/PI3K/AKT biology with translational decisions in respiratory, apoptosis and cancer research.
-
RNA Pol II Inhibition and Regulated Cell Death
2026-08-28
Harper et al. identify an active apoptotic response to loss of hypophosphorylated RNA Pol II, challenging the idea that transcriptional inhibition kills cells only through passive mRNA and protein decay. Their functional-genomics framework defines the Pol II degradation-dependent apoptotic response and offers a strategy for reinterpreting the lethality of transcription-targeting drugs.
-
Carbapenemase Gene Transmission in CREC
2026-08-27
This Guangdong multicenter study maps carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae and distinguishes plasmid-mediated horizontal transfer from strain-level dissemination. Its combination of plasmid elimination, PCR, conjugation, antimicrobial susceptibility testing, and ERIC-PCR provides a practical framework for hospital resistance surveillance.
-
Epmedin C Limits DON Immunotoxicity in Chicken Macrophages
2026-08-27
The reference study identifies caspase-1/IL-1β signaling as a central component of low-dose deoxynivalenol immunotoxicity in chicken macrophages and shows that epmedin C can attenuate this response. By combining cellular experiments, network pharmacology, molecular docking, coculture analysis, and chick validation, the work connects oxidative stress with inflammatory immune dysfunction and suggests a poultry-focused detoxification strategy.
-
Oleanolic Acid, FXR, and Cholestatic Liver Injury
2026-08-26
The 2024 reference study defines a mechanistic link between oleanolic acid exposure, impaired FXR-regulated bile acid efflux, and disruption of hepatocyte tight junctions. Its combined transporter, imaging, and pharmacological-rescue design provides a useful framework for studying cholestasis and FXR signaling pathway dysfunction.
-
Nav1.5 Ser571, Late INa, and the Aging Heart
2026-08-26
The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic relaxation during cardiac aging. Its combination of age comparisons, phosphomimetic and phosphoablated mouse models, cardiac measurements, and myocyte mechanics provides a framework for interpreting late-current inhibition in aging and arrhythmia research.
-
Catalpol Workflows for Neuroprotection Research
2026-08-25
Catalpol supports mechanism-led workflows that connect microglial inflammation, TrkB signaling, neuronal recovery, and tissue-level outcomes. This guide translates the reference study into practical cell, animal, exposure, and troubleshooting strategies while showing how the compound can be extended cautiously into stroke, osteoporosis, and fibrosis research.
-
Recombinant Human EGF in 3D Glioblastoma Assays
2026-08-25
Discover how recombinant human EGF can serve as a controlled perturbation in 3D glioblastoma spheroid assays. This guide connects EGFR biology, product-quality considerations, and the streamlined method reported by Chen and colleagues to improve interpretation of tumor-stemness experiments.